Point72 Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Point72 Asset Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-770,552	Closed	-$1.73M	–	1453
2021 Q4	$1.73M	Buy	+770,552	New	+$1.93M	0.01%	838
2016 Q1	–	Sell	-191,400	Closed	-$1.5M	–	886
2015 Q4	$1.5M	Buy	+191,400	New	+$1.65M	0.01%	578
2014 Q4	–	Sell	-1,700,000	Closed	-$22.8M	–	819
2014 Q3	$22.8M	Sell	1,700,000 -1,710,978	-50%	-$20.4M	0.17%	164
2014 Q2	$43.5M	Buy	+3,410,978	New	+$35.5M	0.28%	101

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Point72 Asset Management's INFI Position: Q1 2022 in Review

Point72 Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2022, closing a stake of 770,552 shares — an estimated $1.73M sold.

Point72 Asset Management first reported a position in INFI in Q2 2014 and held it in 4 quarters. The position peaked at $43.5M in Q2 2014. 93 funds tracked by Wall St. Rank hold INFI as of Q1 2022.

Point72 Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Point72 Asset Management sold 770,552 Infinity Pharmaceuticals, Inc. shares in Q1 2022, an estimated $1.73M.
Point72 Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2014 and held it in 4 quarters.
Point72 Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $43.5M in Q2 2014.
93 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2022.

Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.